Explore the complete record of transactions filed by Navratil Tomas, Directeur. Director active across 1 company, notably GLAUKOS Corp. In total, 45 filings have been logged. Split: 0 buy · 7 sells. Total volume traded: €779k. History available since 1 April 2022. The latest transaction was disclosed on 1 July 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Tomas Navratil serves as the Chief Development Officer at GLAUKOS Corp, an innovative company in the medical device sector. In this role, he oversees the initiatives for developing new products and technologies, contributing to the company's market expansion. Navratil brings valuable expertise in development strategy and innovation.